Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.02 | 0.6 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |